Safety and efficacy of bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients (pts) with relapsed or refractory myelofibrosis (r/r-MF) and other advanced myeloid neoplasms: A phase (Ph) 1 study.
Por:
Watts, JM, Vannucchi, AM, Hunter, A, Gupta, V, Tantravahi, SK, Yuda, J, Iurlo, A, Bose, P, Casares, MTG, McMahon, B, Palandri, F, Searle, E, Xicoy, B, Srisuwananukorn, A, Halpern, AB, Diaz, RA, Hernandez, JM, Tomita, A, Zheng, FD and Vachhani, P
Publicada:
1 jun 2025
Resumen:
Filiaciones:
Univ Miami, Sylvester Canc Ctr, Miami, FL USA
Univ Florence, AOU Careggi, Florence, Italy
Emory Univ, Sch Med, Atlanta, GA USA
Princess Margaret Canc Ctr, Toronto, ON, Canada
Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
Natl Canc Ctr Hosp East, Kashiwa, Japan
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
Univ Texas MD Anderson Canc Ctr, Houston, TX USA
Hosp Univ Gran Canaria Doctor Negrin, Las Palmas Gran Canaria, Spain
Univ Colorado, Sch Med, Div Hematol, Aurora, CO USA
IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy
Christie Hosp NHS Fdn Trust, Manchester, England
Univ Manchester, Manchester, England
Univ Autonoma Barcelona, Hosp Germans Trias i Pujol, Josep Carreras Leukemia Res Inst, Inst Catala Oncol, Badalona, Spain
Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
Univ Washington, Seattle, WA USA
Fred Hutchinson Canc Ctr, Seattle, WA USA
Hosp Univ 12 Octubre, Madrid, Spain
Univ Salamanca, Salamanca, Spain
Fujita Hlth Univ, Sch Med, Toyoake, Japan
Incyte Corp, Wilmington, DE USA
Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
Bronze
|